---
title: "Marchex (MCHX) Receives a Buy from Northland Securities"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295810897.md"
description: "Northland Securities analyst Michael Latimore maintained a Buy rating on Marchex (MCHX) with a $4.00 price target. Latimore, a 4-star analyst, covers the Technology sector. The broader market consensus for Marchex is also a Moderate Buy, aligning with the $4.00 average price target."
datetime: "2026-08-13T13:37:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295810897.md)
  - [en](https://longbridge.com/en/news/295810897.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295810897.md)
generator: "portal-rs"
---

# Marchex (MCHX) Receives a Buy from Northland Securities

In a report released today, Michael Latimore from Northland Securities maintained a Buy rating on Marchex, with a price target of $4.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

According to TipRanks, Latimore is a 4-star analyst with an average return of 11.0% and a 39.10% success rate. Latimore covers the Technology sector, focusing on stocks such as Ondas, Palladyne AI Corp, and Gorilla Technology Group Inc..

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Marchex with a $4.00 average price target.

### Related Stocks

- [MCHX.US](https://longbridge.com/en/quote/MCHX.US.md)
- [ONDS.US](https://longbridge.com/en/quote/ONDS.US.md)
- [PDYN.US](https://longbridge.com/en/quote/PDYN.US.md)
- [GRRR.US](https://longbridge.com/en/quote/GRRR.US.md)
- [PDYNW.US](https://longbridge.com/en/quote/PDYNW.US.md)
- [GRRRW.US](https://longbridge.com/en/quote/GRRRW.US.md)

## Related News & Research

- [Marchex Earnings Call: Archenia Deal Fuels Aggressive Outlook](https://longbridge.com/en/news/296715058.md)
- [Northland Securities Reaffirms Their Buy Rating on Marchex (MCHX)](https://longbridge.com/en/news/293442602.md)
- [Analyst Reiterates Buy on Cogent Biosciences, Maintains $55 Price Target Amid Late-Stage Pipeline and Strong Cash Position](https://longbridge.com/en/news/296384188.md)
- [Morgan Stanley Keeps Their Buy Rating on Netskope, Inc. (NTSK)](https://longbridge.com/en/news/296639611.md)
- [James Schneider Reiterates Buy Rating on Analog Devices with Unchanged $450 Price Target After Strong Beat and Upbeat Outlook](https://longbridge.com/en/news/296383873.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**